NY vs. California vs. Colorado Cannabis Markets Compared

If you've ever traveled to Denver or stepped into a dispensary in Los Angeles, you already know that legal cannabis doesn't look the same everywhere. New York's adult-use cannabis market — launched under the MRTA and built with social equity at its core — is genuinely unlike anything California or Colorado has created. We're Silly Nice, a Black-owned, Veteran-owned, family-run cannabis brand based in Brooklyn, NYC. We launched in March 2024 and we're now in 150+ licensed adult-use dispensaries across New York State. We've watched this market take shape from the inside, and we're here to tell you exactly how it compares — and why we believe New York is on the path to becoming the most meaningful legal cannabis market in the United States.

This isn't brand cheerleading. It's a real, grounded comparison based on what we see every day — talking to New Yorkers from the Bronx to Buffalo, watching product move through dispensary shelves across five boroughs and upstate counties, and understanding firsthand what our community actually wants from legal cannabis. Let's dig in.

Colorado: The Pioneer That Set the Template

Colorado legalized adult-use cannabis in 2012, making it one of the first two states in the country to do so alongside Washington. That early mover advantage gave Colorado a decade-plus head start to build out its regulatory framework, tax infrastructure, testing standards, and retail ecosystem. Today, Colorado's market is mature — almost corporate in places — with hundreds of dispensaries, vertically integrated mega-operators, and price compression that has driven average flower prices well below $10 per gram in many shops. It works. But it's a very different animal than what New York is building.

California: The Biggest Market, the Biggest Headaches

California legalized adult-use in 2016 and has the largest legal cannabis market in the world by revenue. But it has also struggled enormously. High taxes — sometimes exceeding 35% on a single transaction when state, local, and excise taxes stack — have kept the illegal market stubbornly alive. Many cities and counties opted out of allowing retail dispensaries altogether. Getting licensed in California can take years and cost hundreds of thousands of dollars. The result is a two-tiered reality: a gleaming, well-stocked legal market in cities like Los Angeles, San Francisco, and San Diego — sitting directly beside a massive, deeply entrenched unlicensed market that has refused to disappear.

California's social equity promises have largely fallen short. The fees, local approval processes, and capital requirements have made it extraordinarily difficult for small, community-rooted operators to compete with well-funded multistate operators and legacy brands. That's a real problem, and it's one New York's regulators set out to solve — at least in theory.

Social Equity Was Written Into the Foundation

New York's Marijuana Regulation and Taxation Act (MRTA), signed into law in 2021, was intentionally designed to prioritize people most impacted by cannabis prohibition. The Conditional Adult-Use Retail Dispensary (CAURD) license was created specifically for justice-involved individuals — people with prior cannabis convictions — to get first access to the retail market. That's not window dressing. That's a structural decision baked into law. Colorado never did this. California tried, and largely failed to implement it at scale. New York's approach isn't perfect — we've seen real delays, funding shortfalls, and implementation challenges — but the intent is embedded in the architecture of the market in a way the other states never managed.

The Illicit Market Remains New York's Biggest Challenge

Let's be honest about where New York still has work to do. The unlicensed market in New York City — the smoke shops, the gray-market storefronts, the delivery apps operating outside of MRTA compliance — remains enormous. California faced this same problem and never fully solved it. New York is in the middle of that same battle right now. Law enforcement crackdowns have accelerated, and the Office of Cannabis Management has moved to close unlicensed operators. But the density of New York City makes this a uniquely complex enforcement challenge. The good news: licensed dispensaries are expanding rapidly, and products like ours — lab-tested, fully compliant, independently verified — give New Yorkers who care about what they're consuming a clear, trustworthy alternative.

Colorado's Commodity Trap and California's Premium Scene

In Colorado, market maturity has driven prices down dramatically — a gram of flower can run $4 to $6 in many dispensaries. That sounds appealing until you understand what drives those prices: high-volume cultivation, aggressive cost-cutting, and a race to the bottom on quality in many segments of the market. The premium end of Colorado still produces excellent craft products, but the average consumer has been trained by price compression to expect cheap. California sits at the opposite extreme — you'll find some of the most celebrated cannabis brands in the world operating there, with packaging and branding that rivals any luxury consumer goods category. Top-shelf live resin, hash rosin, and solventless concentrates are widely available in LA, the Bay Area, and beyond. The California premium market is genuinely world-class.

New York Is Building Something Worth Believing In

New York is still in its formation years — and we believe those years matter enormously. The brands establishing themselves right now, the quality standards being set, the consumer expectations being shaped — all of it is being written in real time. That's exactly why we made the decisions we made when we built Silly Nice. Our Diamond Powder is 1g of ultra-refined THCa crystalline at 86.24% THC and 98.54% total cannabinoids, priced at $50. Our Frosted Hash Ball — handmade, artisanal, 1g at 67.34% THC with 5.7% terpenes — is $50. Our Bubble Hash, made via ice-water solventless extraction, comes in at 53.32% THC with 6.2% terpene content for $44. Compare that terpene percentage to anything you'll find in a Colorado bargain bin and the difference is visceral.

Our Infused Flower — 3.5g of Papaya Wine coated in live resin and THCa diamonds at 51.22% THC — is $60. Our 510 Vape in Pink Stardust is 1g at 81.96% THC with 100% cannabis-derived terpenes for $40. And our 2G All-In-One in Alaskan Thunder Fuck runs 82.46% THC across 2 full grams for $80, rechargeable via USB-C. Every single one of these products is independently lab-tested. COAs — Certificates of Analysis — are published and publicly accessible at sillynice.com/menu. We don't ask you to trust us blindly. We show you the numbers.

California's Tax Burden Is a Warning Sign

California's cannabis tax structure is notoriously brutal. The state-level excise tax sits at 15%, but local taxes can add another 10–15% depending on the municipality, and the pre-tax cultivation tax compounds the cost before anything even hits a shelf. Many California consumers report paying $70–$90 for an eighth that a Colorado shopper might find for $25. That gap is what keeps the unlicensed market alive in California — and it's a cautionary tale New York needs to take seriously. New York's excise tax is tiered and tied to potency, a structure that's still evolving. But keeping the tax burden manageable is essential to competing with unlicensed product. It's one of the most important policy fights happening in our market right now.

Colorado Found a Balance — But at the Cost of Quality Signals

Colorado's taxes are significant — the state collects a 15% excise tax and a 15% retail marijuana sales tax on top of regular state and local sales taxes — but years of price competition have still pushed retail prices lower than most other legal states. For the cost-conscious consumer, Colorado's market delivers. But there's a trade-off: when price is the primary signal, quality can suffer. Brands competing on the lowest price per gram don't necessarily invest in small-batch cultivation, solventless extraction methods, or the kind of terpene preservation that makes a real difference in the experience for adults 21 and older.

Cannabis Culture Was Always New York Culture

Before there was a legal market, cannabis was already woven into the fabric of New York City's culture — from Harlem to East Flatbush, from Washington Heights to Jamaica, Queens. The music that defined generations, the artistic communities that shaped global culture, the neighborhoods that built American identity — cannabis was part of that story long before a single license was issued. Colorado built its market from a skiing-and-outdoor-recreation culture. California built its market from the intersection of Hollywood, Silicon Valley, and surf culture. New York has something neither of those states can manufacture: an authentic, community-rooted cannabis history that spans every borough, every demographic, every culture.

We're Building for This Community, Full Stop

When Shane Breen — U.S. Army Veteran, co-founder of Silly Nice — and LeVar Thomas built this brand alongside the communities they've been part of for over 25 years, they weren't following a California playbook or mimicking what works in Denver. They were building something for New York: premium, honest, community-grounded, and Black-owned in a market that desperately needed more of exactly that. We are family-run. We are small-batch. We are not trying to be the cheapest option on the shelf. We are trying to be the most trustworthy, the most consistent, and the most connected to the people we actually serve.

What the Other States Got Right, and Where New York Can Go Further

Colorado proved legal cannabis can be a stable, multi-billion-dollar industry. California proved the premium segment can be world-class. But neither state built a market that fully centered the communities most harmed by prohibition, fully controlled the unlicensed market, or fully delivered on the promise of equity. New York has the opportunity — and the explicit mandate — to do all three. That's not a small thing. That's historic. And every licensed dispensary that carries Silly Nice, every New Yorker who chooses a lab-tested product over a gray-market alternative, every family-run brand that carves out sustainable space in this industry — that's what the New York market's success looks like in practice.

We're not naive about the challenges. Licensing delays, enforcement gaps, tax policy uncertainty, and capital access disparities are all real. But we are here — in 150+ licensed dispensaries across New York State, with every product tested, every COA published, every batch made with the intention of earning your trust. For adults 21 and older who care about what they're putting into their bodies, who care about supporting businesses with roots in the communities they come from, New York's legal cannabis market — at its best — is exactly what it should be. Come find us.

Explore more Silly Nice cannabis guides, product deep-dives, and New York dispensary insights below.

How does the New York cannabis market differ from California?

New York’s cannabis market is newer and built on a foundation of equity, focusing on local, small-batch producers like Silly Nice. While California is more established, New York is quickly becoming a leader in premium, artisanal cannabis.

What is the difference between NY and Colorado cannabis?

Colorado has a long-standing recreational market, whereas New York is prioritizing social equity and community-driven business models. This ensures that brands like Silly Nice can bring unique, local culture to the industry.

Is Brooklyn becoming a cannabis hub?

Yes, Brooklyn is rapidly becoming the center of cannabis culture and entrepreneurship in New York. Silly Nice is proud to represent this movement from the heart of Brooklyn.

Where can I find the best cannabis in NYC?

You can find high-quality, lab-tested cannabis products by visiting licensed dispensaries throughout NYC. Look for established brands like Silly Nice for a consistent and premium experience.